Every state, kept current
The Rates plan
$29/mo7-day free trialThis page shows one representative rate per state for Q9999. Full schedules include every locality, modifier, and age-band variant.
- Every code on all 51 published schedules
- Full-schedule CSV export and state network lists
- Email alerts when a state changes its rates
$29/mo after the trial. Cancel anytime.
Publishing states
22
Median % of Medicare
--
Rate range
$12.93 - $43.19
Q9999 rates in every publishing state
| State | Medicaid rate | % of Medicare | Prior auth | Vintage |
|---|---|---|---|---|
| Arkansas | $14.78 | -- | -- | 2026 |
| California | $17.75 | -- | -- | 2026 |
| Connecticut | $32.96 | -- | -- | 2026 |
| District of Columbia | $32.96 | -- | Required | 2026 |
| Idaho | $28.47 | -- | Required | 2026 |
| Illinois | $12.93 | -- | -- | 2026 |
| Kansas | $13.15 | -- | -- | 2026 |
| Michigan | $13.15 | -- | -- | 2026 |
| Minnesota | $13.15 | -- | Required | 2026 |
| Missouri | $29.66* | -- | Not required | 2026 |
| Montana | $32.96 | -- | -- | 2026 |
| Nebraska | $13.15 | -- | -- | 2026 |
| New Hampshire | $40.22 | -- | Not required | 2026 |
| New Jersey | $39.82 | -- | Not required | 2026 |
| Oklahoma | $13.15 | -- | -- | 2026 |
| Rhode Island | $34.18 | -- | -- | 2026 |
| South Carolina | $13.15 | -- | -- | 2026 |
| Texas | $43.19* | -- | -- | 2025 |
| Utah | $13.15* | -- | Required | 2026 |
| Vermont | $31.44 | -- | Required | 2026 |
| Washington | $13.15 | -- | -- | 2026 |
| Wisconsin | $13.15 | -- | -- | 2026 |
Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.
Related state-specific services codes
- C1716 - Brachytherapy source, non-stranded, gold-198, per source
- C1717 - Brachytherapy source, non-stranded, high dose rate iridium-192, per source
- C1719 - Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source
- C2616 - Brachytherapy source, non-stranded, yttrium-90, per source
- C2634 - Brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source
- C2635 - Brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source
- C2636 - Brachytherapy linear source, non-stranded, palladium-103, per 1 mm
- C2638 - Brachytherapy source, stranded, iodine-125, per source
All 22 codes from Q9950 to Q9999 or every state-specific services code by number.
Frequently asked questions
How much does Medicaid pay for Q9999?
22 state Medicaid programs publish a fee-for-service rate for Q9999 (injection, ustekinumab-aauz (otulfi), biosimilar, 1 mg), ranging from $12.93 in Illinois to $43.19 in Texas. The full table on this page lists every publishing state's current rate.
Which state pays the most for Q9999?
Texas publishes the highest Medicaid rate for Q9999 at $43.19. Illinois publishes the lowest at $12.93.
Does Q9999 require prior authorization under Medicaid?
5 of the 22 publishing states flag Q9999 as requiring prior authorization (always or conditionally) on their fee schedules. States without a flag publish no PA indicator for this code - that means "not published", not "no PA required".